Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy
Journal of Clinical and Experimental Hematopathology · 2024
DOI: 10.3960/jslrt.24026 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2024. Verfasst von Takayoshi Uchiyama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Niigata University of Pharmacy and Medical and Life Sciences, Faculty of Medical Technology, Niigata City, Niigata, Japan. Hauptthemen laut MEDLINE: Lymphadenopathy, Castleman Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Niigata University of Pharmacy and Medical and Life Sciences, Faculty of Medical Technology, Niigata City, Niigata, Japan.
Zitieren
APA
Uchiyama, T., Yokoyama, A., Kuroda, Y., & Aoki, S. (2024). Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24026
Vancouver
Uchiyama T, Yokoyama A, Kuroda Y, Aoki S. Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy. Journal of Clinical and Experimental Hematopathology. 2024. doi:10.3960/jslrt.24026
BibTeX
@article{Uchiyama2024,
author = {Uchiyama, Takayoshi and Yokoyama, Aki and Kuroda, Yuzu and Aoki, Sadao},
title = {Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2024},
doi = {10.3960/jslrt.24026}
}
EUVIMED